PICC P&C (02328): Lu Chen's qualifications for the position of Executive Director have been approved.
China Pacific Insurance (02328) announced that it has recently received a response from the National Financial Supervision and Administration Commission regarding the qualifications of Mr. Lu Chen. According to this response, the National Financial Supervision and Administration Commission has approved Mr. Lu Chen's qualifications to serve as a director of the company. Mr. Lu Chen's roles as the company's executive director and as a member of the Board Strategic Planning Committee/Sustainable Development Committee, the Board Risk Management and Consumer Rights Protection Committee (Asset Liability Management and Investment Decision Committee), and the Board Related Party Transaction Control Committee will take effect on August 4, 2026.
PICC P&C (02328) announced that the company has recently received a reply from the National Financial Supervision and Administration Commission regarding Mr. Lv Chen's qualifications for the position. According to this reply, the National Financial Supervision and Administration Commission has approved Mr. Lv Chen's qualifications to serve as a director of the company. Mr. Lv Chen's positions as the company's executive director and a member of the Board's Strategic Planning Committee/Sustainable Development Committee, the Board's Risk Management and Consumer Rights Protection Committee (Asset and Liability Management and Investment Decision-making Committee), and the Board's Related Party Transaction Control Committee will take effect on August 4, 2026.
Related Articles
Guangdong Create Century Intelligent Equipment Group Corporation (300083.SZ) plans to implement a restricted stock incentive plan in 2026.
Merck & Co., Inc. (MRK.US) has submitted its oral drug for the treatment of AIDS for market approval in China.
Suzhou Novosense Microelectronics (02676): Wang Shengyang appointed as Chairman and General Manager
Guangdong Create Century Intelligent Equipment Group Corporation (300083.SZ) plans to implement a restricted stock incentive plan in 2026.
Merck & Co., Inc. (MRK.US) has submitted its oral drug for the treatment of AIDS for market approval in China.
Suzhou Novosense Microelectronics (02676): Wang Shengyang appointed as Chairman and General Manager
RECOMMEND
